PGC1α-mediated Mitofusin-2 Deficiency in Female Rats and Humans with Pulmonary Arterial Hypertension-Reference-Cited by-同舟云学术

PGC1α-mediated Mitofusin-2 Deficiency in Female Rats and Humans with Pulmonary Arterial Hypertension

Published:2013-04-15 Issue:8 Volume:187 Page:865-878
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Ryan John J.,Marsboom Glenn,Fang Yong-Hu,Toth Peter T.,Morrow Erik,Luo Nancy,Piao Lin,Hong Zhigang,Ericson Kyle,Zhang Hannah J.,Han Mei,Haney Chad R.,Chen Chin-Tu,Sharp Willard W.,Archer Stephen L.

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference55 articles.

1. Pulmonary Arterial Hypertension

2. Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension

3. Familial Primary Pulmonary Hypertension (Gene PPH1) Is Caused by Mutations in the Bone Morphogenetic Protein Receptor–II Gene

4. Primary Pulmonary Hypertension Is Associated With Reduced Pulmonary Vascular Expression of Type II Bone Morphogenetic Protein Receptor

5. Basic Science of Pulmonary Arterial Hypertension for Clinicians

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The protective mechanism of sevoflurane in pulmonary arterial hypertension via downregulation of TRAF6;Toxicology and Applied Pharmacology;2024-10

2. Unraveling the Mfn2-Warburg effect nexus: a therapeutic strategy to combat pulmonary arterial hypertension arising from catch-up growth after IUGR;Respiratory Research;2024-09-02

3. Mitochondrial quality control in human health and disease;Military Medical Research;2024-05-29

4. Peptides Are Cardioprotective Drugs of the Future: The Receptor and Signaling Mechanisms of the Cardioprotective Effect of Glucagon-like Peptide-1 Receptor Agonists;International Journal of Molecular Sciences;2024-04-30

5. Mitochondrial network dynamics in pulmonary disease: Bridging the gap between inflammation, oxidative stress, and bioenergetics;Redox Biology;2024-04